BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37401089)

  • 1. Detection of Glioma-Related Hotspot Mutations Through Sequencing of Cerebrospinal Fluid (CSF)-Derived Circulating Tumor DNA: A Pilot Study on CSF-Based Liquid Biopsy for Primary Spinal Cord Astrocytoma.
    Cheng L; Duan W; Guan J; Wang K; Liu Z; Wang X; Wang Z; Wu H; Chen Z; Jian F
    Neurospine; 2023 Jun; 20(2):701-708. PubMed ID: 37401089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors.
    Chai R; An S; Lin H; Pang B; Yan H; Liu Y; Wu Y; Wang L; Liu X; Chen H; Yang X; Chang Q; Jia W; Wang Y
    NPJ Precis Oncol; 2024 Feb; 8(1):43. PubMed ID: 38388726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid.
    Martínez-Ricarte F; Mayor R; Martínez-Sáez E; Rubio-Pérez C; Pineda E; Cordero E; Cicuéndez M; Poca MA; López-Bigas N; Ramon Y Cajal S; Vieito M; Carles J; Tabernero J; Vivancos A; Gallego S; Graus F; Sahuquillo J; Seoane J
    Clin Cancer Res; 2018 Jun; 24(12):2812-2819. PubMed ID: 29615461
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid.
    Fujioka Y; Hata N; Akagi Y; Kuga D; Hatae R; Sangatsuda Y; Michiwaki Y; Amemiya T; Takigawa K; Funakoshi Y; Sako A; Iwaki T; Iihara K; Mizoguchi M
    J Neurooncol; 2021 Mar; 152(1):47-54. PubMed ID: 33417137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
    Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X
    Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal ependymoma.
    Connolly ID; Li Y; Pan W; Johnson E; You L; Vogel H; Ratliff J; Hayden Gephart M
    J Neurooncol; 2017 Oct; 135(1):29-36. PubMed ID: 28900844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA.
    Pan C; Diplas BH; Chen X; Wu Y; Xiao X; Jiang L; Geng Y; Xu C; Sun Y; Zhang P; Wu W; Wang Y; Wu Z; Zhang J; Jiao Y; Yan H; Zhang L
    Acta Neuropathol; 2019 Feb; 137(2):297-306. PubMed ID: 30460397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma.
    Huang TY; Piunti A; Lulla RR; Qi J; Horbinski CM; Tomita T; James CD; Shilatifard A; Saratsis AM
    Acta Neuropathol Commun; 2017 Apr; 5(1):28. PubMed ID: 28416018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance analysis of cerebrospinal fluid with the tumor tissue for integrated diagnosis in gliomas based on next-generation sequencing.
    Wang Q; Liang Q; Wei W; Niu W; Liang C; Wang X; Wang X; Pan H
    Pathol Oncol Res; 2023; 29():1611391. PubMed ID: 37822669
    [No Abstract]   [Full Text] [Related]  

  • 10. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA.
    Azad TD; Jin MC; Bernhardt LJ; Bettegowda C
    Neurosurg Focus; 2020 Jan; 48(1):E9. PubMed ID: 31896079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
    Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
    Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driver Genetic Mutations in Spinal Cord Gliomas Direct the Degree of Functional Impairment in Tumor-Associated Spinal Cord Injury.
    Nagashima Y; Nishimura Y; Ohka F; Eguchi K; Aoki K; Ito H; Nishii T; Oyama T; Hara M; Kitano Y; Masaki H; Wakabayashi T; Natsume A
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).
    Li M; Chen J; Zhang B; Yu J; Wang N; Li D; Shao Y; Zhu D; Liang C; Ma Y; Ou Q; Hou X; Chen L
    BMC Med; 2022 Nov; 20(1):398. PubMed ID: 36372873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma.
    Fontanilles M; Deniel A; Marguet F; Beaussire L; Magne N; Derrey S; Blanchard F; Alexandru C; Coutant S; Laquerrière A; Clatot F; Di Fiore F; Sarafan-Vasseur N
    Rev Neurol (Paris); 2022 Nov; 178(9):975-980. PubMed ID: 35871016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors.
    Ronsley R; Karvonen KA; Cole B; Paulson V; Stevens J; Crotty EE; Hauptman J; Lee A; Stasi SM; Lockwood CM; Leary SES
    J Neurooncol; 2024 Jun; 168(2):215-224. PubMed ID: 38755519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas.
    On J; Natsumeda M; Watanabe J; Saito S; Kanemaru Y; Abe H; Tsukamoto Y; Okada M; Oishi M; Yoshimura J; Kakita A; Fujii Y
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33918936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine.
    Pagès M; Rotem D; Gydush G; Reed S; Rhoades J; Ha G; Lo C; Fleharty M; Duran M; Jones R; Becker S; Haller M; Sinai CE; Goumnerova L; Golub TR; Love JC; Ligon KL; Wright KD; Adalsteinsson VA; Beroukhim R; Bandopadhayay P
    Neuro Oncol; 2022 Aug; 24(8):1352-1363. PubMed ID: 34984433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of mutation profiles and tumor mutation burden of cerebrospinal fluid circulating DNA by a cancer genomic panel sequencing in glioma patients.
    Guo W; Jin L; Liang J; Lin G; Zheng J; Zhou D; Zhan S; Sun H; Jiang X
    Clin Chim Acta; 2022 Sep; 534():81-92. PubMed ID: 35810802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, radiological and molecular characterization of intramedullary astrocytomas.
    Lebrun L; Meléndez B; Blanchard O; De Nève N; Van Campenhout C; Lelotte J; Balériaux D; Riva M; Brotchi J; Bruneau M; De Witte O; Decaestecker C; D'Haene N; Salmon I
    Acta Neuropathol Commun; 2020 Aug; 8(1):128. PubMed ID: 32771057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
    Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
    Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.